Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer |
| |
Authors: | Borut Kragelj Lijana Zaletel-Kragelj |
| |
Affiliation: | Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia. jasx77@gmail.com |
| |
Abstract: | Tolerability to gemcitabine radiochemotherapy was evaluated in 33 patients with inoperable, locally advanced transitional-cell bladder cancers. The dose of 75 mg/m(2) gemcitabine once a week, concurrently with standard radiotherapy of 60 Gy/6 weeks, was found to be acceptable. Eighty-one percentage of 3-year local progression-free survival suggests efficiency warranting further studies. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|